DOCSLIB.ORG

5159.Full.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
5159.Full.Pdf Inhibition of T Cell Activation by Cyclic Adenosine 5 ′-Monophosphate Requires Lipid Raft Targeting of Protein Kinase A Type I by the A-Kinase Anchoring Protein Ezrin This information is current as of October 1, 2021. Anja Ruppelt, Randi Mosenden, Mikaela Grönholm, Einar M. Aandahl, Derek Tobin, Cathrine R. Carlson, Hilde Abrahamsen, Friedrich W. Herberg, Olli Carpén and Kjetil Taskén J Immunol 2007; 179:5159-5168; ; Downloaded from doi: 10.4049/jimmunol.179.8.5159 http://www.jimmunol.org/content/179/8/5159 References This article cites 63 articles, 39 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/179/8/5159.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Inhibition of T Cell Activation by Cyclic Adenosine 5؅-Monophosphate Requires Lipid Raft Targeting of Protein Kinase A Type I by the A-Kinase Anchoring Protein Ezrin1 Anja Ruppelt,* Randi Mosenden,* Mikaela Gro¨nholm,† Einar M. Aandahl,* Derek Tobin,2* Cathrine R. Carlson,3* Hilde Abrahamsen,4* Friedrich W. Herberg,‡ Olli Carpe´n,†§ and Kjetil Taske´n5* cAMP negatively regulates T cell immune responses by activation of type I protein kinase A (PKA), which in turn phosphorylates and activates C-terminal Src kinase (Csk) in T cell lipid rafts. Using yeast two-hybrid screening, far-Western blot, immunopre- cipitation and immunofluorescense analyses, and small interfering RNA-mediated knockdown, we identified Ezrin as the A-kinase anchoring protein that targets PKA type I to lipid rafts. Furthermore, Ezrin brings PKA in proximity to its downstream substrate Downloaded from Csk in lipid rafts by forming a multiprotein complex consisting of PKA/Ezrin/Ezrin-binding protein 50, Csk, and Csk-binding protein/phosphoprotein associated with glycosphingolipid-enriched microdomains. The complex is initially present in immuno- logical synapses when T cells contact APCs and subsequently exits to the distal pole. Introduction of an anchoring disruptor peptide (Ht31) into T cells competes with Ezrin binding to PKA and thereby releases the cAMP/PKA type I-mediated inhibition of T cell proliferation. Finally, small interfering RNA-mediated knockdown of Ezrin abrogates cAMP regulation of IL-2. We propose that Ezrin is essential in the assembly of the cAMP-mediated regulatory pathway that modulates T cell immune http://www.jimmunol.org/ responses. The Journal of Immunology, 2007, 179: 5159–5168. yclic AMP and protein kinase A (PKA)6 mediate intra- expression of PKA isoforms with different biochemical properties. cellular signals from a wide variety of hormones, neuro- In addition, A-kinase anchoring proteins (AKAPs) target PKA iso- C transmitters, growth factors, and cytokines (1). cAMP forms to defined subcellular sites in close proximity to relevant and PKA signaling affect a range of cellular processes, strongly substrates (2). AKAPs may also tune the sensitivity of the signal suggesting that this signaling pathway has the capacity to provide pathway by recruiting PKA into multiprotein complexes that may rapid and precise signaling with the required sensitivity and spec- include phosphodiesterases and protein phosphatases as well as ificity. Specificity can be achieved by tissue and cell type-specific other signal proteins (3). by guest on October 1, 2021 There are two major isoforms of PKA in eukaryotes, PKA type I and II. These isoforms can be distinguished by their regulatory *The Biotechnology Centre of Oslo, University of Oslo, Oslo, Norway; †Biomedicum Helsinki, Department of Pathology, University of Helsinki and Helsinki University subunits labeled RI and RII. Activation occurs upon binding of Central Hospital, Helsinki, Finland; ‡Institut fu¨r Biochemie, Universita¨t Kassel, Kas- cAMP to the R subunits, followed by the release of the active sel, Germany; and §Department of Pathology, University of Turku and Turku Uni- catalytic subunit. PKA type II is mainly particulate and associated versity Central Hospital, Turku, Finland with AKAPs, whereas PKA type I is both soluble and particulate. Received for publication March 19, 2007. Accepted for publication August 7, 2007. During T cell activation, PKA type I is redistributed during for- The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance mation of the immunological synapse and colocalizes with the with 18 U.S.C. Section 1734 solely to indicate this fact. TCR-CD3 complex (4). PKA type I inhibits T cell activation by 1 This work was supported by grants from The National Programme for Research in activation of C-terminal Src kinase (Csk) through phosphory- Functional Genomics in Norway, The Research Council of Norway, The Norwegian lation of serine 364 in Csk (5). Active Csk subsequently phos- Cancer Society, Novo Nordic Foundation Committee, the European Union (Grants QLK3-CT-2002-02149 and 037189, thera-cAMP), and the Deutsche Forschungsge- phorylates the C-terminal inhibitory tyrosine residue of Lck and meinschaft (He1818/3). thereby acts as a negative regulator of TCR signaling. Although 2 Current address: Diagenic ASA, N-0663 Oslo, Norway. the molecular details of this process are well understood, it is 3 Current address: Institute of Experimental Medical Research, Ullevål University not known how PKA type I is localized to lipid rafts during T Hospital, N-0407 Oslo, Norway. cell activation. 4 Current address: Department of Pharmacology, University of California San Diego, Ezrin is a 78-kDa protein belonging to the Ezrin-Radixin-Moe- La Jolla, CA 92093. sin (ERM) family of proteins that play structural and regulatory 5 Address correspondence and reprint requests to Dr. Kjetil Taske´n, The Biotechnol- roles in the assembly and stabilization of specialized plasma mem- ogy Centre, University of Oslo, P.O. Box 1125, Blindern, N-0317 Oslo, Norway. E-mail address: [email protected] brane domains by linking microfilaments to the membrane. ERM 6 Abbreviations used in this paper: PKA, protein kinase A; AKAP, A-kinase anchor- proteins have a highly homologous N-terminal 4.1/ezrin/radixin/ ing protein; Cbp, Csk-binding protein; CFTR, cystic fibrosis transmembrane conduc- moesin (FERM) domain and bind directly to a number of trans- tance regulator; 8-CPT, 8-(4-chlorophenylthio)-cAMP; Csk, C-terminal Src kinase; membrane proteins, including CD44, the transmembrane protein EBP50, Ezrin-Radixin-Moesin-binding phosphoprotein 50; FERM, 4.1/ezrin/radixin/ moesin; IPTG, isopropyl ␤-D-thiogalactoside; LAT, linker for activation of T cells; Na/H exchanger NEH1, CD43, and ICAMs (6–10), in addition to PAG, phosphoprotein associated with glycosphingolipid-enriched microdomain; indirect binding to other membrane proteins via the scaffolding PVDF, polyvinylidene difluoride; siRNA, small interfering RNA. proteins ERM-binding phosphoprotein 50 (EBP50) and sodium- Copyright © 2007 by The American Association of Immunologists, Inc. 0022-1767/07/$2.00 hydrogen exchanger type 3 kinase A regulatory protein. The www.jimmunol.org 5160 EZRIN TARGETS PKA TYPE I TO T CELL LIPID RAFTS FERM domain also binds to signaling molecules in the Rho path- Purification, culture, and transfection of human peripheral way, including Rho guanine dinucleotide dissociation domain and blood T cells and Jurkat T cells Dbl (11, 12). Most of Ezrin’s interactions are dependent on con- The human leukemic T cell line Jurkat Tag was cultured and transfected, formational activation of the molecule. In a dormant state, binding as described elsewhere (5). Purification of peripheral blood CD3ϩ T cells sites for interaction partners are masked due to an intramolecular by negative selection from buffycoats of normal healthy donors (Ullevaal interaction between the FERM domain and the C terminus. Upon University Hospital Blood Center) and T cell proliferation assays was con- ducted, as described in detail elsewhere (20). For transfections of periph- phosphorylation of a C-terminal threonine (T567) by protein ki- ϫ 6 ␳ eral blood T cells, cells (5 10 ) in 0.1 ml of Nucleofection solution nase C or kinase, the intramolecular bond is released and other (Amaxa) were mixed with 1200 nM siRNA and subjected to electropora- interactions can occur (13). tion in a Nucleofector (Amaxa) following the manufacturer’s protocol. The Previous reports have suggested that Ezrin recruits type II PKA cells were expanded in complete medium and incubated for 20 h at 37°C. 5 to the secretory canaliculi in gastric parietal cells when stimulated A total of 4 ϫ 10 T cells was treated with 10 ␮M, 50 ␮M, or without cAMP 15 min (37°C) and subsequently activated by addition of 8 ␮lof by gastrin (14). Ezrin has
Load more

Recommended publications
  • Activated Ezrin Controls MISP Levels to Ensure Correct Numa Polarization and Spindle Orientation Yvonne T
    © 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs214544. doi:10.1242/jcs.214544 RESEARCH ARTICLE Activated ezrin controls MISP levels to ensure correct NuMA polarization and spindle orientation Yvonne T. Kschonsak1,2 and Ingrid Hoffmann1,* ABSTRACT misregulation in spindle orientation can result in disorganized tissue Correct spindle orientation is achieved through signaling pathways that morphology due to cell multi-layering, which could be associated provide a molecular link between the cell cortex and spindle with the earliest cancer developments (McCaffrey and Macara, microtubules in an F-actin-dependent manner. A conserved cortical 2011; Pease and Tirnauer, 2011). protein complex, composed of LGN (also known as GPSM2), NuMA The precise spindle position and orientation in the cell is achieved (also known as NUMA1) and dynein–dynactin, plays a key role in by signaling pathways generating pulling and pushing forces on the establishing proper spindle orientation. It has also been shown that the spindle, both externally or internally (Gönczy, 2002; Grill and actin-binding protein MISP and the ERM family, which are activated by Hyman, 2005; Théry et al., 2005; Fink et al., 2011). The longest lymphocyte-oriented kinase (LOK, also known as STK10) and Ste20- established player in spindle orientation is the conserved ternary α like kinase (SLK) (hereafter, SLK/LOK) in mitosis, regulate spindle complex, composed of G i, Leu-Gly-Asn repeat-enriched protein orientation. Here, we report that MISP functions downstream of the (LGN, also known as GPSM2) and nuclear mitotic apparatus ERM family member ezrin and upstream of NuMA to allow optimal (NuMA, also known as NUMA1) (Du et al., 2001; Du and Macara, α spindle positioning.
    [Show full text]
  • Expression of Ezrin, CD44, and VEGF in Giant Cell Tumor of Bone and Its
    Zhang et al. World Journal of Surgical Oncology (2015) 13:168 DOI 10.1186/s12957-015-0579-5 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Expression of ezrin, CD44, and VEGF in giant cell tumor of bone and its significance Jing Zhang1†, Jian Dong1†, Zuozhang Yang1*†, Xiang Ma1†, Jinlei Zhang1†, Mei Li2, Yun Chen2, Yingying Ding3, Kun Li3 and Zhiping Zhang3 Abstract Background: This research aimed to study the role of ezrin, CD44, and VEGF in invasion, metastasis, recurrence, and prognosis of giant cell tumor of bone (GCTB) and its association with the clinical and pathological features of GCTB. Methods: Expression status of ezrin, CD44, and VEGF in 80 GCTB tissues and its adjacent noncancerous tissue samples were measured with immunohistochemical and Elivison staining. Their correlation with the clinical and pathologic factors was statistically analyzed by chi-square test. Results: The expression status of ezrin, CD44, and VEGF were significantly higher in GCTB tissue samples than in its adjacent noncancerous tissue samples and in GCTB at Campanacci stage III than in Campanacci stages I and II (P < 0.05). No significant difference was found in age and sex of the patients and locations of the tumor (P > 0.05). Survival analysis showed that the expression status of ezrin, CD44, VEGF, and Campanacci clinical stages of GCTB were positively associated with the survival rate of GCTB patients and negatively associated with ezrin and Campanacci stages of GCTB, indicating that ezrin, CD44, VEGF, and Campanacci clinical stages of GCTB are the independent factors for GCTB. Conclusions: Ezrin, CD44, and VEGF are over-expressed in GCTB tissue and its adjacent noncancerous tissue samples and may play an important role in the occurrence, invasion, metastasis, and recurrence of GCTB.
    [Show full text]
  • Adhesion Transendothelial Migration Without Affecting VCAM-1 Inhibits
    An Antibody to the Sixth Ig-like Domain of VCAM-1 Inhibits Leukocyte Transendothelial Migration without Affecting Adhesion This information is current as of September 28, 2021. Sukmook Lee, Il-Hee Yoon, Aerin Yoon, Joan M. Cook-Mills, Chung-Gyu Park and Junho Chung J Immunol published online 1 October 2012 http://www.jimmunol.org/content/early/2012/10/01/jimmun ol.1103803 Downloaded from Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published October 1, 2012, doi:10.4049/jimmunol.1103803 The Journal of Immunology An Antibody to the Sixth Ig-like Domain of VCAM-1 Inhibits Leukocyte Transendothelial Migration without Affecting Adhesion Sukmook Lee,*,1,2 Il-Hee Yoon,*,†,1 Aerin Yoon,‡ Joan M. Cook-Mills,x Chung-Gyu Park,†,3 and Junho Chung‡,3 VCAM-1 plays a key role in leukocyte trafficking during inflammatory responses.
    [Show full text]
  • Polarity: Merlin and Ezrin Get Organized
    RESEARCH HIGHLIGHTS Nature Reviews Cancer | AOP, published online 10 January 2013; doi:10.1038/nrc3453 POLARITY Merlin and ezrin get organized The ezrin, radixin and moesin (ERM) proteins and the closely related tumour suppressor neuro­ fibromatosis type 2 (NF2; also known as merlin) function as scaffolds to organize the cell cortex localization and to help regulate cell polarity of ezrin all during epithelial morphogenesis, around the cell cortex. a process that is often disrupted in Therefore, NF2 seems to tumorigenesis. However, how NF2 be involved in restricting the and the ERM proteins achieve this localization of ezrin, a process organization, and the functional that the authors found requires relationship among these proteins, is α-catenin; this is interesting as it not completely clear. indicates a junction-independent Andrea McClatchey and col­ function for α-catenin. leagues followed the localization of Given the connections of the ezrin and NF2 during the establish­ ezrin cap to the cell cycle, the authors ment of apical–basal polarity in also examined the centrosomes and Lara Crow/NPG single Caco2 intestinal epithelial cells mitotic spindle position in single embedded in Matrigel. They noted Caco2 cells; they found that their (these mice eventually develop renal that ezrin became restricted into localization was tightly correlated carcinomas), and ectopic ezrin a cap-like structure at the plasma with the ezrin cap. Supporting this, localization and multi-layering in the membrane prior to the first cell centrosomes in cells expressing NF2 colon. In addition, cancer cells often division. The cells were uniformly shRNA were found near areas of have extra centrosomes; these can surrounded by extracellular matrix the cortex with ectopic ezrin, and be clustered to allow the cell to form and the cap lacked markers of apical spindles were aberrantly oriented in bipolar spindles, but loss of clustering polarity, indicating that intrinsic these cells.
    [Show full text]
  • And Heterotypic Interaction of Merlin and Ezrin
    Journal of Cell Science 112, 895-904 (1999) 895 Printed in Great Britain © The Company of Biologists Limited 1999 JCS0140 Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin Mikaela Grönholm1,*, Markku Sainio1, Fang Zhao1, Leena Heiska1, Antti Vaheri2 and Olli Carpén1 Departments of 1Pathology and 2Virology, University of Helsinki, Haartman Institute, PO Box 21 (Haartmaninkatu 3), FIN-00014 Helsinki *Author for correspondence (e-mail: mikaela.gronholm@helsinki.fi) Accepted 23 December 1998; published on WWW 25 February 1999 SUMMARY Ezrin, radixin and moesin (ERM) are homologous proteins, involves interaction between the amino- and carboxy- which are linkers between plasma membrane components termini. The amino-terminal association domain of merlin and the actin-containing cytoskeleton. The ERM protein involves residues 1-339 and has similar features with the family members associate with each other in a homotypic amino-terminal association domain of ezrin. The carboxy- and heterotypic manner. The neurofibromatosis 2 (NF2) terminal association domain cannot be mapped as precisely tumor suppressor protein merlin (schwannomin) is as in ezrin, but it requires residues 585-595 and a more structurally related to ERM members. Merlin is involved amino-terminal segment. Unlike ezrin, merlin does not in tumorigenesis of NF2-associated and sporadic require activation for self-association but native merlin schwannomas and meningiomas, but the tumor suppressor molecules can interact with each other. Heterodimerization mechanism is poorly understood. We have studied the between merlin and ezrin, however, occurs only following ability of merlin to self-associate and bind ezrin. Ezrin was conformational alterations in both proteins.
    [Show full text]
  • Fas Role in Ischemic Stroke; Not Only in Apoptosis
    a ular nd G ec en l e o t i M c f M Sergeeva et al., J Mol Genet Med 2016, 10:4 o l e d Journal of Molecular and Genetic a i n c r DOI: 10.4172/1747-0862.1000236 i n u e o J ISSN: 1747-0862 Medicine ReviewResearch Article Article Open Access Fas Role in Ischemic Stroke: Not Only in Apoptosis Sergeeva SP1, Gorbacheva LR2,3*, Breslavich ID4 and Cherdak MA5 1Department of Pathophysiology, I.M Sechenov First Moscow State Medical University, Trubetskaya Street, 8-2, Moscow, Russia 2Department of Physiology, Pirogov Russian National Research Medical University, Ostrovitianov Street, 1, Moscow, Russia 3Department of Physiology, Lomonosov Moscow State University, Leninskiye Gory, 1, Moscow, Russia 4Faculty of Mechanics and Mathematics, Lomonosov Moscow State University, GSP-1, 1 Leninskiye Gory, 1, Moscow, Russia 5Department of Neurological Diseases, I.M. Sechenov First Moscow State Medical University, Trubetskaya street, Moscow, Russia Abstract The receptors, whose ligand interaction activation was previously considered to be associated with initiation of apoptosis only, can have a range of biological effects: apoptosis, inflammation, proliferation, and differentiation. Therefore, interaction between death receptor and its ligand does not always mean the initiation of programmed cell death and blocking of this ligand-receptor interaction can affect the initiation of recovery and neuroplasticity mechanisms. Fas is one of these death receptors. The following review represents data on the conditions of Fas- dependent signal pathways induction in ischemic stroke. There is a possibility for the development of new target neuroprotective drugs with selective effects on different separated signal pathways, activated by ligand-receptor interactions in Fas-FasL (Fas ligand) system.
    [Show full text]
  • ERM Protein Family
    Cell Biology 2018; 6(2): 20-32 http://www.sciencepublishinggroup.com/j/cb doi: 10.11648/j.cb.20180602.11 ISSN: 2330-0175 (Print); ISSN: 2330-0183 (Online) Structure and Functions: ERM Protein Family Divine Mensah Sedzro 1, †, Sm Faysal Bellah 1, 2, †, *, Hameed Akbar 1, Sardar Mohammad Saker Billah 3 1Laboratory of Cellular Dynamics, School of Life Science, University of Science and Technology of China, Hefei, China 2Department of Pharmacy, Manarat International University, Dhaka, Bangladesh 3Department of Chemistry, Govt. M. M. University College, Jessore, Bangladesh Email address: *Corresponding author † These authors contributed equally to this work To cite this article: Divine Mensah Sedzro, Sm Faysal Bellah, Hameed Akbar, Sardar Mohammad Saker Billah. Structure and Functions: ERM Protein Family. Cell Biology . Vol. 6, No. 2, 2018, pp. 20-32. doi: 10.11648/j.cb.20180602.11 Received : September 15, 2018; Accepted : October 6, 2018; Published : October 29, 2018 Abstract: Preservation of the structural integrity of the cell depends on the plasma membrane in eukaryotic cells. Interaction between plasma membrane, cytoskeleton and proper anchorage influence regular cellular processes. The needed regulated connection between the membrane and the underlying actin cytoskeleton is therefore made available by the ERM (Ezrin, Radixin, and Moesin) family of proteins. ERM proteins also afford the required environment for the diffusion of signals in reactions to extracellular signals. Other studies have confirmed the importance of ERM proteins in different mode organisms and in cultured cells to emphasize the generation and maintenance of specific domains of the plasma membrane. An essential attribute of almost all cells are the specialized membrane domains.
    [Show full text]
  • Ezrin Intracellular Cytoskeleton Marker Is Over Expressed in Pancreatic Ductal Adenocarcinoma: a Prospective Cohort Study
    Research Article Clinics in Oncology Published: 01 Mar, 2021 Ezrin Intracellular Cytoskeleton Marker is Over Expressed in Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study Livia Petrusel1, Ioana Rusu2, Ramona Suharoschi3, Andrada Seicean1, Daniel Corneliu Leucuta4* and Radu Seicean5 1Department of Gastroenterology, Iuliu Hatieganu University of Medicine and Pharmacy, Romania 2Department of Pathology, Iuliu Hatieganu University of Medicine and Pharmacy, Romania 3Department of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, Romania 4Department of Medical Informatics and Biostatistics, Iuliu Hatieganu University of Medicine and Pharmacy, Romania 5First Surgery Clinic, Iuliu Hatieganu University of Medicine and Pharmacy, Romania Abstract Background: Intracellular cytoskeleton in Pancreatic Ductal Adenocarcinoma (PDAC) might be a key factor in its poor outcome. Reliable biomarkers estimating the cytoskeleton involvement are lacking. Ezrin is involved in intracellular signaling and adhesion, by linking in the PI3K/Akt pathways. Aim of the Study: To assess the significance of ezrin protein expression in PDAC related to the clinical stage and survival. Methods: This prospective cohort study enrolled patients with proven adenocarcinoma and a matched group of controls without any malignancies. The plasma levels of ezrin were analyzed using western blotting and were correlated with the clinicopathological features and survival data. These results were validated by immunohistochemical analyses of the pancreatic tumor tissue of the OPEN ACCESS patients included in the study and a supplementary group of surgically resected specimens from *Correspondence: patients with a benign disease. Daniel Corneliu Leucuta, Department Results: The study comprised 51 patients with PDAC, 53 controls and a supplementary group of of Medical Informatics and Biostatistics, 13 normal pancreatic tissue samples.
    [Show full text]
  • Molecular Biology of the Cell Et Al., 2007)
    MBoC | ARTICLE CD43 interaction with ezrin-radixin-moesin (ERM) proteins regulates T-cell trafficking and CD43 phosphorylation J. L. Cannona,*, P. D. Modya, K. M. Blainea, E. J. Chenb, A. D. Nelsona, L. J. Saylesa, T. V. Moorec, B. S. Claya, N. O. Dulina, R. A. Shillinga,c, J. K. Burkhardtb, and A. I. Sperlinga,c aSection of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Chicago, IL 60637; bDepartment of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA 19104; cCommittee on Immunology, University of Chicago, Chicago, IL 60637 ABSTRACT Cell polarization is a key feature of cell motility, driving cell migration to tissues. Monitoring Editor CD43 is an abundantly expressed molecule on the T-cell surface that shows distinct localiza- Josephine Clare Adams tion to the migrating T-cell uropod and the distal pole complex (DPC) opposite the immuno- University of Bristol logical synapse via association with the ezrin-radixin-moesin (ERM) family of actin regulatory Received: Jul 13, 2010 proteins. CD43 regulates multiple T-cell functions, including T-cell activation, proliferation, Revised: Jan 7, 2011 apoptosis, and migration. We recently demonstrated that CD43 regulates T-cell trafficking Accepted: Jan 19, 2011 through a phosphorylation site at Ser-76 (S76) within its cytoplasmic tail. Using a phosphory- lation-specific antibody, we now find that CD43 phosphorylation at S76 is enhanced by mi- gration signals. We further show that CD43 phosphorylation and normal T-cell trafficking depend on CD43 association with ERM proteins. Interestingly, mutation of S76 to mimic phosphorylation enhances T-cell migration and CD43 movement to the DPC while blocking ERM association, showing that CD43 movement can occur in the absence of ERM binding.
    [Show full text]
  • Sox2 Antagonizes the Hippo Pathway to Maintain Stemness in Cancer Cells
    ARTICLE Received 5 Jun 2014 | Accepted 27 Jan 2015 | Published 2 Apr 2015 DOI: 10.1038/ncomms7411 Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells Upal Basu-Roy1, N. Sumru Bayin2, Kirk Rattanakorn1, Eugenia Han1,3, Dimitris G. Placantonakis2, Alka Mansukhani1 & Claudio Basilico1 The repressive Hippo pathway has a profound tumour suppressive role in cancer by restraining the growth-promoting function of the transcriptional coactivator, YAP. We previously showed that the stem cell transcription factor Sox2 maintains cancer stem cells (CSCs) in osteosarcomas. We now report that in these tumours, Sox2 antagonizes the Hippo pathway by direct repression of two Hippo activators, Nf2 (Merlin) and WWC1 (Kibra), leading to exaggerated YAP function. Repression of Nf2, WWC1 and high YAP expression marks the CSC fraction of the tumor population, while the more differentiated fraction has high Nf2, high WWC1 and reduced YAP expression. YAP depletion sharply reduces CSCs and tumorigenicity of osteosarcomas. Thus, Sox2 interferes with the tumour-suppressive Hippo pathway to maintain CSCs in osteosarcomas. This Sox2-Hippo axis is conserved in other Sox2-dependent cancers such as glioblastomas. Disruption of YAP transcriptional activity could be a therapeutic strategy for Sox2-dependent tumours. 1 Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA. 2 Department of Neurosurgery, New York University School of Medicine, New York, New York 10016, USA. 3 Department of Pediatrics, NYU Cancer Institute, New York University School of Medicine, New York, New York 10016, USA. Correspondence and requests for materials should be addressed to A.M. (email: [email protected]) or to C.B.
    [Show full text]
  • Tyrosine-Phosphorylated Ezrin Cell Antigen Receptor by Spatial Coupling of JNK Activation to the B
    Spatial Coupling of JNK Activation to the B Cell Antigen Receptor by Tyrosine-Phosphorylated Ezrin This information is current as Neetha Parameswaran, Gospel Enyindah-Asonye, Nayer of September 24, 2021. Bagheri, Neilay B. Shah and Neetu Gupta J Immunol 2013; 190:2017-2026; Prepublished online 21 January 2013; doi: 10.4049/jimmunol.1201292 http://www.jimmunol.org/content/190/5/2017 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/01/22/jimmunol.120129 Material 2.DC1 http://www.jimmunol.org/ References This article cites 40 articles, 20 of which you can access for free at: http://www.jimmunol.org/content/190/5/2017.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 24, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Spatial Coupling of JNK Activation to the B Cell Antigen Receptor by Tyrosine-Phosphorylated Ezrin Neetha Parameswaran, Gospel Enyindah-Asonye, Nayer Bagheri,1 Neilay B.
    [Show full text]
  • Hedgehog-Independent Overexpression of Transforming Growth Factor-ß1 in Rhabdomyosarcoma of Patched1 Mutant Mice
    405-412 4/7/07 11:15 Page 405 INTERNATIONAL JOURNAL OF ONCOLOGY 31: 405-412, 2007 405 Hedgehog-independent overexpression of transforming growth factor-ß1 in rhabdomyosarcoma of Patched1 mutant mice MELANIE EICHENMÜLLER1, REGINE BAUER2, DIETRICH VON SCHWEINITZ1, HEIDI HAHN2 and ROLAND KAPPLER1,2 1Pediatric Surgical Clinic, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, D-80337 Munich; 2Institute of Human Genetics, University of Goettingen, D-37073 Goettingen, Germany Received March 16, 2007; Accepted May 11, 2007 Abstract. The tumor suppressor gene PATCHED1 (PTCH1) Introduction is a member of the hedgehog signaling pathway and causatively associated with several human sporadic and RMS is the most common soft-tissue sarcoma in children, familial cancers, including those of the skin, muscle and representing approximately 9% of pediatric solid cancers (1). brain. Inactivation of one Ptch1 allele in the mouse results in This tumor is thought to arise as a consequence of regulatory the development of medulloblastoma and rhabdomyosarcoma disruption of skeletal muscle progenitor cell growth and (RMS), the latter being a malignant tumor of skeletal muscle differentiation, yet the precise cell of origin is not entirely clear origin. To identify genes involved in the pathogenesis of (2). The two major histopathological classifications of RMS, Ptch1-associated RMS, we have monitored the expression of the embryonal form (ERMS) and the rarer alveolar form 588 genes in RMS and normal skeletal muscle (SM) of (ARMS), are described to distinguish the two types not only heterozygous Ptch1neo67/+ mice using cDNA array technology. regarding their histology and their degree of differentiation, RMS displayed increased transcript levels of several genes but also their prognosis (3).
    [Show full text]